| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.68B | +26.1% |
| Cost of Revenue | $515.5M | +25.8% |
| Gross Profit | $2.17B | +26.2% |
| R&D Expense | $1.15B | +19.8% |
| SG&A Expense | $205.2M | +13.9% |
| Operating Income | $54.3M | +262.2% |
| Pre-tax Income | $203.9M | +238.6% |
| Income Tax | $20.2M | +73.1% |
| Net Income | $183.7M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.25B | +277.5% |
| Accounts Receivable | $598.9M | +17.6% |
| Current Assets | $4.91B | +54.5% |
| Total Assets | $5.79B | +47.0% |
| Current Liabilities | $1.86B | +85.7% |
| Total Liabilities | $3.07B | +60.7% |
| Stockholders' Equity | $2.71B | +34.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $870.6M | +31.9% |
| Capital Expenditures | $34.7M | +25.9% |
| Investing Cash Flow | -$736.8M | -0.7% |
| Financing Cash Flow | $787.1M | +1250.5% |
| Free Cash Flow | $835.9M | +32.2% |
| +278.3% |
| EPS (Basic) | $0.55 | +266.7% |
| EPS (Diluted) | $0.52 | +271.4% |